ici 118551 and xamoterol

ici 118551 has been researched along with xamoterol in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19903 (25.00)18.7374
1990's4 (33.33)18.2507
2000's2 (16.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, JG; Fischer, PM; Gardiner, SM; Hill, SJ; Kellam, B; Mistry, SN1
Bals, S; Brodde, OE; Deighton, NM; Motomura, S; Zerkowski, HR1
Nagao, T; Narita, H; Watanabe, H; Yabana, H1
McCaffrey, PM; Riddell, JG; Shanks, RG2
Fitzgerald, DE1
Huttunen, J; Larsen, TA; Teräväinen, H1
Fischmeister, R; Jurevicius, J; Skeberdis, VA1
Haynes, JM1
Bellantuono, V; Cassano, G; Lippe, C1
Baker, JG; Fretwell, L; Gardiner, SM; Hill, SJ; Kemp, P; March, J1
Ouyang, M; Schutsky, K; Thomas, SA1

Trials

3 trial(s) available for ici 118551 and xamoterol

ArticleYear
Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
    European heart journal, 1990, Volume: 11 Suppl A

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Male; Prenalterol; Propanolamines; Xamoterol

1990
The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
    Journal of cardiovascular pharmacology, 1988, Volume: 11, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Male; Posture; Prenalterol; Propanolamines; Regional Blood Flow; Tremor; Xamoterol

1988
Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor.
    Acta neurologica Scandinavica, 1986, Volume: 74, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Propanolamines; Propranolol; Random Allocation; Tremor; Xamoterol

1986

Other Studies

9 other study(ies) available for ici 118551 and xamoterol

ArticleYear
Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists.
    Journal of medicinal chemistry, 2013, May-23, Volume: 56, Issue:10

    Topics: Adrenergic beta-1 Receptor Agonists; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Heart Rate; Hemodynamics; Humans; Indicators and Reagents; Ligands; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Structure-Activity Relationship

2013
Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Aged; Calcium; Deoxyepinephrine; Dobutamine; Dopamine; Ethanolamines; Female; Heart Atria; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Propanolamines; Stimulation, Chemical; Xamoterol

1992
Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
    British journal of pharmacology, 1992, Volume: 106, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Bisoprolol; Ethanolamines; Guinea Pigs; Heart; Heart Rate; Histamine; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth; Papillary Muscles; Propanolamines; Trachea; Xamoterol

1992
Effect of xamoterol on peripheral blood vessels in healthy subjects.
    British journal of clinical pharmacology, 1989, Volume: 28 Suppl 1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Ankle; Arm; Blood Pressure; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Male; Propanolamines; Regional Blood Flow; Rheology; Xamoterol

1989
Pharmacological characterization of the receptors involved in the beta-adrenoceptor-mediated stimulation of the L-type Ca2+ current in frog ventricular myocytes.
    British journal of pharmacology, 1997, Volume: 121, Issue:7

    Topics: Albuterol; Animals; Calcium Channels; Calcium Channels, L-Type; Dobutamine; Dose-Response Relationship, Drug; In Vitro Techniques; Isoproterenol; Myocardium; Propanolamines; Rana esculenta; Receptors, Adrenergic, beta; Xamoterol

1997
beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
    European journal of pharmacology, 2007, Sep-10, Volume: 570, Issue:1-3

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Calcium; Cells, Cultured; Cyclic AMP; Ethanolamines; Humans; Isoproterenol; Male; Phenylephrine; Potassium Channel Blockers; Propanolamines; Propranolol; Prostate; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Stromal Cells; Xamoterol

2007
The adrenergic receptor subtypes present in frog (Rana esculenta) skin.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2008, Volume: 148, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amphibian Proteins; Animals; Calmodulin; Chlorides; Clonidine; Cyclic AMP; Dose-Response Relationship, Drug; Ethanolamines; Formoterol Fumarate; Imidazoles; Membrane Potentials; Propanolamines; Rana esculenta; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Signal Transduction; Skin; Sodium; Xamoterol

2008
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:12

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol

2011
Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi/o-coupled β2-adrenergic signaling.
    Learning & memory (Cold Spring Harbor, N.Y.), 2011, Volume: 18, Issue:9

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Behavior, Animal; Chi-Square Distribution; Conditioning, Classical; Conditioning, Operant; Dose-Response Relationship, Drug; Emotions; Fear; GTP-Binding Protein alpha Subunits, Gi-Go; Hippocampus; Memory Disorders; Mental Recall; Mice; Mice, Inbred C57BL; Mice, Knockout; Pertussis Toxin; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Signal Transduction; Time Factors; Xamoterol

2011